Nalaganje...
Mechanistic Correlates of Clinical Responses to Omalizumab in the Setting of Oral Immunotherapy for Milk Allergy
BACKGROUND: In our recent clinical trial, the addition of omalizumab to oral immunotherapy (OIT) for milk allergy improved safety but no significant clinical benefit was detected. OBJECTIVE: To investigate mechanisms by which omalizumab modulates immunity in the context of OIT, and to identify basel...
Shranjeno v:
izdano v: | J Allergy Clin Immunol |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
2017
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632581/ https://ncbi.nlm.nih.gov/pubmed/28414061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.03.028 |
Oznake: |
Označite
Brez oznak, prvi označite!
|